Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpts.com
ENDPOINTS NEWS
Get the latest updates from ENDPOINTS NEWS directly as they happen.
Follow now 184 followers
Latest posts
Last updated 20 minutes ago
Researchers implant human neurons in mice brains to study disease
21 minutes ago
“There is now a mouse, the cortex of which is filled with...
Novo signs Anthropic deal to test Claude Science in R&D
about 1 hour ago
Anthropic is deepening ties with the Danish drugmaker Novo, in the latest...
Novartis' TREM2 drug fails Phase 2 ALS trial
about 4 hours ago
Novartis has scrapped development of a Phase 2 treatment candidate for amyotrophic...
Sling gets $123M for Phase 3 trial of ex-Astellas drug in thyroid eye disease
about 4 hours ago
Investors are pumping $123 million into a tiny Michigan biotech that is...
Skyhawk says its Huntington’s drug improved symptoms in extension to Phase 1/2 trial
about 4 hours ago
Skyhawk Therapeutics’ RNA-splicing candidate for Huntington’s disease improved patients’ symptoms in an...
Klomp, Warren spar over MFN deal contracts
about 21 hours ago
Top HHS official Chris Klomp had a relatively mild nomination hearing with...
FDA approves first radioligand generic, setting up rivalry with Novartis
about 22 hours ago
For the first time, Novartis’ leadership in the radioligand field will be...
Centric Compounding recalls three injectables over contamination
about 23 hours ago
Centric Compounding is undergoing a nationwide recall of three injectable drugs over...
Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis
about 24 hours ago
Sionna Therapeutics announced it was laying off 46% of its staff as...
Rocket's Danon plans; Novo leaves Ascendis; Lilly's latest deal
1 day ago
Plus news about Corbus, Syntis, Arrowhead, BioMarin, BioVie, Agomab, Antelope Therapeutics, Connect...
FDA leaders say they've woven feedback into new trial pilot
1 day ago
The FDA’s long-awaited expedited investigational new drug pilot program began accepting applications...
Axoltis says its Phase 2 study for an experimental ALS drug failed
1 day ago
The French biotech Axoltis Pharma reported a Phase 2 failure in ALS...